Related references
Note: Only part of the references are listed.Temozolomide Treatment Induces HMGB1 to Promote the Formation of Glioma Stem Cells via the TLR2/NEAT1/Wnt Pathway in Glioblastoma
Xiang-Yu Gao et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)
CFTR promotes malignant glioma development via up-regulation of Akt/Bcl2-mediated anti-apoptosis pathway
Minyue Zhao et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2020)
CFTR Modulator Therapy Enhances Peripheral Blood Monocyte Contributions to Immune Responses in People With Cystic Fibrosis
Katherine B. Hisert et al.
FRONTIERS IN PHARMACOLOGY (2020)
Ivacaftor decreases monocyte sensitivity to interferon-γ in people with cystic fibrosis
Katherine B. Hisert et al.
ERJ OPEN RESEARCH (2020)
PAQR4 promotes chemoresistance in non-small cell lung cancer through inhibiting Nrf2 protein degradation
Peifang Xu et al.
THERANOSTICS (2020)
Gboxin is an oxidative phosphorylation inhibitor that targets glioblastoma
Yufeng Shi et al.
NATURE (2019)
Elexacaftor/Ivacaftor/Tezacaftor: First Approval
Sheridan M. Hoy
DRUGS (2019)
YTHDF1 links hypoxia adaptation and non-small cell lung cancer progression
Yulin Shi et al.
NATURE COMMUNICATIONS (2019)
CFTR activation suppresses glioblastoma cell proliferation, migration and invasion
Xiao Zhong et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2019)
Ibrutinib inactivates BMX-STAT3 in glioma stem cells to impair malignant growth and radioresistance
Yu Shi et al.
SCIENCE TRANSLATIONAL MEDICINE (2018)
GRK5 functions as an oncogenic factor in non-small-cell lung cancer
Li-Ping Jiang et al.
CELL DEATH & DISEASE (2018)
VDAC2 interacts with PFKP to regulate glucose metabolism and phenotypic reprogramming of glioma stem cells
Kai Zhou et al.
CELL DEATH & DISEASE (2018)
Impact of CFTR modulation with Ivacaftor on Gut Microbiota and Intestinal Inflammation
Chee Y. Ooi et al.
SCIENTIFIC REPORTS (2018)
NCAPH plays important roles in human colon cancer
Liang Yin et al.
CELL DEATH & DISEASE (2017)
Metabolic Reprogramming in Glioma
Marie Strickland et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2017)
Inhibition of Dopamine Receptor D4 Impedes Autophagic Flux, Proliferation, and Survival of Glioblastoma Stem Cells
Sonam Dolma et al.
CANCER CELL (2016)
Nuclear GSK3β promotes tumorigenesis by phosphorylating KDM1A and inducing its deubiquitylation by USP22
Aidong Zhou et al.
NATURE CELL BIOLOGY (2016)
Temozolomide resistance in glioblastoma multiforme
Sang Y. Lee
GENES & DISEASES (2016)
Cancer stem cells in glioblastoma
Justin D. Lathia et al.
GENES & DEVELOPMENT (2015)
Mesenchymal Differentiation Mediated by NF-κB Promotes Radiation Resistance in Glioblastoma
Krishna P. L. Bhat et al.
CANCER CELL (2013)
Activation of PI3K/Akt pathway by CD133-p85 interaction promotes tumorigenic capacity of glioma stem cells
Yuanyan Wei et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
A restricted cell population propagates glioblastoma growth after chemotherapy
Jian Chen et al.
NATURE (2012)
Cancer stem cells and glioma
Sunit Das et al.
NATURE CLINICAL PRACTICE NEUROLOGY (2008)
CD133 positive hepatocellular carcinoma cells possess high capacity for tumorigenicity
Shengyong Yin et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma
R Stupp et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Share Paper
